Femasys (FEMY) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precision Optics (POCI) has outperformed Femasys (FEMY) over the past year, gaining 7.2% versus a loss of 82.9%. Over five years, POCI leads with a -29.3% price change compared with -98.5% for FEMY. Precision Optics is the larger company by market cap ($51.2 million vs $17.1 million), about 3.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FEMY | POCI |
|---|---|---|
| Share price | $2.05 | $4.67 |
| Market cap | $17.13M | $51.19M |
| 1-day change | +2.25% | +3.21% |
| YTD return | -82.25% | +11.34% |
| 1-year return | -82.87% | +7.24% |
| 5-year return | -98.54% | -29.32% |
| Forward P/E | — | 155.50 |
| EPS (TTM) | $-3.28 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.20 | $6.15 |
| 52-week low | $1.94 | $3.55 |
| Distance from 52-week high | -90.79% | -24.15% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +600.73% | +71.49% |
| Average volume | 722.09K | 51.88K |
| Shares outstanding | 8.38M | 10.97M |
| Employees | 51 | 108 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precision Optics is about 3.0 times larger than Femasys by market value ($51.19M vs $17.13M).
- POCI has outperformed FEMY by 90.1 percentage points over the past year.
About Femasys
FEMY stock →Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.
Health Care · Medical/Dental Instruments · 51 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
FEMY vs POCI FAQ
Which is bigger, Femasys or Precision Optics?
Precision Optics (POCI) is larger, with a market capitalization of $51.19M compared with $17.13M for Femasys (FEMY).
Which stock has performed better over the past year, FEMY or POCI?
POCI returned +7.24% over the past 12 months, compared with -82.87% for FEMY (price return, excluding dividends). Past performance does not predict future results.
Are Femasys and Precision Optics in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Femasys and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Precision Optics.